Showing results (671-680 of 2,445) with videos related to
Sort By:
Pageof 245
Journal of the National Comprehensive Cancer Network : JNCCN|January 6, 2022
COVID-19 and Cancer Center Operations: Lessons Learned From the NCCN Best Practices CommitteeJessica M Sugalski, Theresa Franco, Lawrence N Shulman, et al.Journal of the National Comprehensive Cancer Network : JNCCN|January 6, 2022
Representation and Outcomes of Older Adults in Practice-Changing Oncology Trials in the Era of Novel Therapies: A Guideline AppraisalRonald Chow, Daniel E Lage, Grant R Williams, et al.Journal of the National Comprehensive Cancer Network : JNCCN|January 6, 2022
Optimizing Thromboembolism Prophylaxis for the Contemporary Age of Multiple MyelomaMuhamed Baljevic, Douglas W Sborov, Ming Y Lim, et al.Journal of the National Comprehensive Cancer Network : JNCCN|December 6, 2021
Involving Family and Social Support Systems in Tobacco Cessation Treatment for Patients With CancerJournal of the National Comprehensive Cancer Network : JNCCN|December 7, 2021
Comorbidities, Rather Than Older Age, Are Strongly Associated With Higher Utilization of Healthcare in Colorectal Cancer SurvivorsMelissa S Y Thong, Daniel Boakye, Lina Jansen, et al.Journal of the National Comprehensive Cancer Network : JNCCN|December 7, 2021
Hitting the Right Spot: Advances in the Treatment of NSCLC With Uncommon EGFR MutationsJoshua K Sabari, John V Heymach, Beth SandyJournal of the National Comprehensive Cancer Network : JNCCN|November 15, 2021
Survivorship Issues in Adult Patients With Histiocytic NeoplasmsKevin O'Brien, Rahul Dave, Skand Shekhar, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2021
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021Andrew D Zelenetz, Leo I Gordon, Julie E Chang, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2021
Histiocytic Neoplasms, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyRonald S Go, Eric Jacobsen, Robert Baiocchi, et al.Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2022
Intravenous Patient-Controlled Analgesia Versus Oral Opioid to Maintain Analgesia for Severe Cancer Pain: A Randomized Phase II TrialRongbo Lin, Jinfeng Zhu, Yushuang Luo, et al.Pageof 245